Vaickus L - Search Results

1

Acute progranulocytic leukemia (APL): possible in vivo differentiation by granulocyte colony-stimulating factor (G-CSF).

Vaickus L, Villalona-Calero MA, Caligiuri T. Vaickus L, et al. Leukemia. 1993 Oct;7(10):1680-1. Leukemia. 1993. PMID: 7692195 No abstract available.

2

Granulocyte-macrophage colony-stimulating factor as infection prophylaxis in high-risk oncologic surgery.

Meropol NJ, Petrelli NJ, Lipman BJ, Rodriguez-Bigas M, Hicks W, Douglass HO Jr, Smith JL, Rasey M, Blumenson LE, Vaickus L, Hayes FA, Agosti JM. Meropol NJ, et al. Among authors: vaickus l. Am J Surg. 1996 Sep;172(3):299-302. doi: 10.1016/s0002-9610(96)00106-7. Am J Surg. 1996. PMID: 8862090 Clinical Trial.

3

Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity.

Meropol NJ, Porter M, Blumenson LE, Lindemann MJ, Perez RP, Vaickus L, Loewen GM, Creaven PJ, Wilkes KA, Giedlin MA, Caligiuri MA. Meropol NJ, et al. Among authors: vaickus l. Clin Cancer Res. 1996 Apr;2(4):669-77. Clin Cancer Res. 1996. PMID: 9816217

4

Unusual gastrointestinal complications of interleukin-2 therapy.

Rahman R, Bernstein Z, Vaickus L, Penetrante R, Arbuck S, Kopec I, Vesper D, Douglass HO Jr, Foon KA. Rahman R, et al. Among authors: vaickus l. J Immunother (1991). 1991 Jun;10(3):221-5. doi: 10.1097/00002371-199106000-00009. J Immunother (1991). 1991. PMID: 1868046

5

Interleukin-2 lymphokine-activated killer cell therapy of non-Hodgkin's lymphoma and Hodgkin's disease.

Bernstein ZP, Vaickus L, Friedman N, Goldrosen MH, Watanabe H, Rahman R, Arbuck SG, Sweeney J, Vesper D, Henderson ED, et al. Bernstein ZP, et al. Among authors: vaickus l. J Immunother (1991). 1991 Apr;10(2):141-6. doi: 10.1097/00002371-199104000-00008. J Immunother (1991). 1991. PMID: 2043594

6

Renal cell carcinoma treated with continuous-infusion interleukin-2 with ex vivo-activated killer cells.

Foon KA, Walther PJ, Bernstein ZP, Vaickus L, Rahman R, Watanabe H, Sweeney J, Park J, Vesper D, Russell D, et al. Foon KA, et al. Among authors: vaickus l. J Immunother (1991). 1992 Apr;11(3):184-90. doi: 10.1097/00002371-199204000-00005. J Immunother (1991). 1992. PMID: 1515423 Clinical Trial.

7

Interleukin-2 with ex vivo activated killer cells: therapy of advanced non-small-cell lung cancer.

Bernstein ZP, Goldrosen MH, Vaickus L, Friedman N, Watanabe H, Rahman R, Park J, Arbuck SG, Sweeney J, Vesper DS, et al. Bernstein ZP, et al. Among authors: vaickus l. J Immunother (1991). 1991 Oct;10(5):383-7. doi: 10.1097/00002371-199110000-00012. J Immunother (1991). 1991. PMID: 1665077 Clinical Trial.

8

Carboplatin for small cell lung cancer: progress toward greater efficacy and reduced toxicity.

Raghavan D, Perez R, Creaven P, Takita H, Loewen G, Vaickus L. Raghavan D, et al. Among authors: vaickus l. Semin Oncol. 1994 Jun;21(3 Suppl 6):1-8. Semin Oncol. 1994. PMID: 8052868 Review.

9

Malignancy-related pericardial effusion. 127 cases from the Roswell Park Cancer Institute.

Wilkes JD, Fidias P, Vaickus L, Perez RP. Wilkes JD, et al. Among authors: vaickus l. Cancer. 1995 Oct 15;76(8):1377-87. doi: 10.1002/1097-0142(19951015)76:8<1377::aid-cncr2820760813>3.0.co;2-m. Cancer. 1995. PMID: 8620412 Review.

10

Interferon gamma augments Lym-1-dependent, granulocyte-mediated tumor cell lysis.

Vaickus L, Biddle W, Cemerlić D, Foon KA. Vaickus L, et al. Blood. 1990 Jun 15;75(12):2408-16. Blood. 1990. PMID: 2140949 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters